Stocks in play: Héroux-Devtek Inc.
Announced that the Toronto Stock Exchange has approved the renewal of its normal course issuer bid. Under the NCIB, Héroux-Devtek has the right to purchase for cancellation, from May 25, 2022 to May 24, 2023, a maximum of 1,896,079 common shares, representing, as of May 11, 2022, 10% of the public float of 18,960,792 common shares. The Corporation had 34,486,776 common shares issued and outstanding as of May 11. Héroux-Devtek Inc. shares T.HRX are trading unchanged at $14.25.
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.